The first Chancellor’s Lecture of the academic year, entitled “Genomes, Hype and a Realistic Pathway to Personalized Medicine,” will be given Wednesday, Sept. 12, by Dan Roden, M.D., assistant vice chancellor for Personalized Medicine at Vanderbilt University.

This month BioVU logged in its 150,000th unique genetic sample. It is now the world’s largest collection of human DNA linked to searchable, electronic health information.

Females may be at higher risk of potentially fatal heart condition due to gender differences in a protein involved in the heart’s electrical activity.

Individuals with atrial fibrillation who have a particular genetic variant respond better to rate control therapy.

Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death.